Microbial Medical, Inc. is an innovative healthcare company specializing in the development of a novel PET-based imaging agent for the in vivo diagnosis and localization of bacterial infections. Our conjugated imaging agent, designed for use in common medical scanners, delivers high specificity and sensitivity when differentiating infections from benign inflammation. The technology leverages the unique bacterial uptake of maltodextrins, labeled with 18F for precise targeting and has successfully completed animal studies and is currently progressing through Phase I human trials.